5 things for Life Sciences organizations to consider when choosing a document-to-PDF conversion platform

August 7, 2014

2 minute read

Life Sciences best practices guide CTALearn how to select the perfect document-to-PDF software for your Life Sciences organization

Life Sciences organizations are faced with dealing with millions of pages of content – for FDA submissions, clinical trials, manufacturing records and more – and these files come in a range of file formats: Word, Excel, CAD, JPEG…the list goes on.

In order to battle this influx of content and to manage it effectively, organizations – and not just in the Life Sciences – are converting all of their documents to a PDF standard. This ensures that users don’t require special viewing software to open the files, and that files can remain secure and accurate for many years to come.

However, there are literally hundreds of PDF conversion tools out on the market which range from basic freeware products to larger enterprise-scale Advanced Rendering software. Take a look at this infographic for a detailed account on the many types of PDF conversion products available.

Choosing the right PDF conversion software

There are 5 critical questions all Life Sciences organizations should ask when selecting an enterprise-grade PDF conversion tool to transform their millions of files to PDF format:

  1. Will the product work with the existing and multiple sources of content?
  2. Is it possible to render all text within the documents searchable?
  3. Can the product help the organization meet compliance requirements?
  4. Will it be possible to unify multiple systems with the same document conversion platform?
  5. What are the archiving and long-term retention capabilities of the product?

Once an organization is able to understand the implications of each of the above questions, they can make an informed decision on which PDF conversion software to choose. For more details, check out this new white paper on how to select an enterprise-grade document-to-PDF solution for pharmaceutical firms, biotechnology organizations and medical device manufacturers.

Don’t forget to share this post